Jose J. Echegaray
University of Miami
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Jose J. Echegaray.
International Journal of Inflammation | 2013
Fernando Cruz-Guilloty; Ali M. Saeed; Jose J. Echegaray; Stephanie Duffort; Asha Ballmick; Yaohong Tan; Michel Betancourt; Eduardo Viteri; Ghansham C. Ramkhellawan; Eric Ewald; William J. Feuer; DeQiang Huang; Rong Wen; Li Hong; Hua Wang; James Laird; Abdoulaye Sene; Rajendra S. Apte; Robert G. Salomon; Joe G. Hollyfield; Victor L. Perez
Age-related macular degeneration (AMD) is a major cause of blindness in the developed world. Oxidative stress and inflammation are implicated in AMD, but precise mechanisms remain poorly defined. Carboxyethylpyrrole (CEP) is an AMD-associated lipid peroxidation product. We previously demonstrated that mice immunized with CEP-modified albumin developed AMD-like degenerative changes in the outer retina. Here, we examined the kinetics of lesion development in immunized mice and the presence of macrophages within the interphotoreceptor matrix (IPM), between the retinal pigment epithelium and photoreceptor outer segments. We observed a significant and time-dependent increase in the number of macrophages in immunized mice relative to young age-matched controls prior to overt pathology. These changes were more pronounced in BALB/c mice than in C57BL/6 mice. Importantly, IPM-infiltrating macrophages were polarized toward the M1 phenotype but only in immunized mice. Moreover, when Ccr2-deficient mice were immunized, macrophages were not present in the IPM and no retinal lesions were observed, suggesting a deleterious role for these cells in our model. This work provides mechanistic evidence linking immune responses against oxidative damage with the presence of proinflammatory macrophages at sites of future AMD and experimentally demonstrates that manipulating immunity may be a target for modulating the development of AMD.
Journal of Ophthalmology | 2014
Hua Gao; Peng Song; Jose J. Echegaray; Yanni Jia; Suxia Li; Man Du; Victor L. Perez; Weiyun Shi
Objective. To evaluate the therapeutic effect of big bubble deep anterior lamellar keratoplasty (DALK) in patients with deep fungal keratitis. Methods.Consecutive patients who had DALK for deep fungal keratitis at Shandong Eye Hospital between July 2011 and December 2012 were included. In all patients, the infiltration depth was more than 4/5ths of the corneal thickness. DALK surgery was performed with bare Descemet membrane (DM) using the big bubble technique. Corrected distance visual acuity (CDVA), graft status, and intraoperative and postoperative complications were monitored. Results. Big bubble DALK was performed in 23 patients (23 eyes). Intraoperative perforation of the DM occurred in two eyes (8.7%) during stromal dissection. The patients received lamellar keratoplasty with an air bubble injected into the anterior chamber. Double anterior chamber formed in 3 eyes (13.0%). Mean CDVA of the patients without cataract, amblyopia, and fungal recurrence was improved from preoperative HM/20 cm−1.0 (LogMAR) to 0.23 ± 0.13 (LogMAR) at the last followup (P < 0.01). Fungal recurrence was found in two patients (8.7%). Corneal stromal graft rejection was noted in one patient (4.3%). Conclusions. DALK using the big bubble technique seems to be effective and safe in the treatment of deep fungal keratitis unresponsive to medication.
Oncotarget | 2017
Sander R. Dubovy; Maria Paula Fernandez; Jose J. Echegaray; Norman L. Block; Noriyuki Unoki; Roberto Perez; Irving Vidaurre; Richard K. Lee; Mehrdad Nadji; Andrew V. Schally
Extrapituitary roles for hypothalamic neurohormones have recently become apparent and clinically relevant, based on the use of synthetic peptide analogs for the treatment of multiple conditions including cancers, pulmonary edema and myocardial infarction. In the eye, it has been suggested that some of these hormones and their receptors may be present in the ciliary body, iris, trabecular meshwork and retina, but their physiological role has yet to be elucidated. Our study intends to comprehensively demonstrate the expression of some hypothalamic neuroendocrine hormones and their receptors within different retinal and extraretinal structures of the human eye. Immunofluorescence, Western blot analysis, and RT-PCR were used to evaluate the qualitative and quantitative expression of Luteinizing Hormone Releasing Hormone (LHRH), Growth Hormone Releasing Hormone (GHRH), Thyrotropin Releasing Hormone (TRH), Gastrin Releasing Peptide (GRP) and Somatostatin as well as their respective receptors (LHRH-R, GHRH-R, TRH-R, GRP-R, SST-R1) in cadaveric human eye tissue and in paraffinized human eye tissue sections. The hypothalamic hormones LHRH, GHRH, TRH, GRP and Somatostatin and their respective receptors (LHRH-R, GHRH-R, TRH-R, GRPR/BB2 and SST-R1), were expressed in the conjunctiva, cornea, trabecular meshwork, ciliary body, lens, retina, and optic nerve.Extrapituitary roles for hypothalamic neurohormones have recently become apparent and clinically relevant, based on the use of synthetic peptide analogs for the treatment of multiple conditions including cancers, pulmonary edema and myocardial infarction. In the eye, it has been suggested that some of these hormones and their receptors may be present in the ciliary body, iris, trabecular meshwork and retina, but their physiological role has yet to be elucidated. Our study intends to comprehensively demonstrate the expression of some hypothalamic neuroendocrine hormones and their receptors within different retinal and extraretinal structures of the human eye. Immunofluorescence, Western blot analysis, and RT-PCR were used to evaluate the qualitative and quantitative expression of Luteinizing Hormone Releasing Hormone (LHRH), Growth Hormone Releasing Hormone (GHRH), Thyrotropin Releasing Hormone (TRH), Gastrin Releasing Peptide (GRP) and Somatostatin as well as their respective receptors (LHRH-R, GHRH-R, TRH-R, GRP-R, SST-R1) in cadaveric human eye tissue and in paraffinized human eye tissue sections. The hypothalamic hormones LHRH, GHRH, TRH, GRP and Somatostatin and their respective receptors (LHRH-R, GHRH-R, TRH-R, GRPR/BB2 and SST-R1), were expressed in the conjunctiva, cornea, trabecular meshwork, ciliary body, lens, retina, and optic nerve.
Graefes Archive for Clinical and Experimental Ophthalmology | 2014
Hua Gao; Xiuxian Wang; Jose J. Echegaray; Suxia Li; Ting Wang; Weiyun Shi
Molecular Vision | 2013
Mohamed Abou Shousha; Andrea Rachelle C. Santos; Rafael A. Oechsler; Alfonso Iovieno; Jorge Maestre-Mesa; Marco Ruggeri; Jose J. Echegaray; Sander R. Dubovy; Victor L. Perez; Darlene Miller; Eduardo C. Alfonso; M. Livia Bajenaru
Current Immunology Reviews | 2011
Jose J. Echegaray; Victor L. Perez
Archive | 2015
Jose J. Echegaray; Fernando Cruz-Guilloty; Priscilla Cristovam; Victor L. Perez
Investigative Ophthalmology & Visual Science | 2012
Nicholas J. Cutrufello; Samantha Herretes; Jose J. Echegaray; Victor L. Perez
Investigative Ophthalmology & Visual Science | 2010
Jose J. Echegaray; Michelle Senchyna; David L. Meadows; Howard Allen Ketelson; Victor L. Perez
Investigative Ophthalmology & Visual Science | 2010
Jose J. Echegaray; F. Cruz Guilloty; E. J. Ewald; Victor L. Perez